Brief: InspireMD And NAMSA To Partner On CGuardians II Pivotal Clinical Trial Of The CGuard Prime 80 Cm Carotid Stent System For Use In TCAR Procedures
13/02/2025 12:07
Feb 13 (Reuters) - InspireMD Inc NSPR.O :
* INSPIREMD AND NAMSA TO PARTNER ON CGUARDIANS II PIVOTAL
CLINICAL
TRIAL OF THE CGUARD PRIME™ 80 CM CAROTID STENT SYSTEM FOR USE IN
TCAR PROCEDURES
Source text: ID:nGNX3VgBGy
Further company coverage: NSPR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on InspireMD
See all newsInspireMD Inc reports results for the quarter ended June 30 - Earnings Summary
InspireMD Q2 revenue beats estimates on international demand
InspireMD Inc expected to post a loss of 20 cents a share - Earnings Preview
InspireMD Inc expected to post a loss of 20 cents a share - Earnings Preview
InspireMD Q1 revenue jumps 122%, beats estimates on product demand